PV00091

Organization name

i+Med S.Coop.

SRN

ES-MF-000008633

Manufacturer status

Active

9 warnings recorded — scroll inside the panel to see all entries.

• CW009

  EUDAMED did not publish a description for this code.
• CW001

  EUDAMED did not publish a description for this code.
• CW135

  Keep out of children's reach. Jonexa Up should not be administered to children
• CW032

  The product should not be used after the expiration date
• CW276

  Do not use with other products containing quaternary ammonium salts as benzalkonium chloride or with any surgical material treated with this type of substances because sodium hyaluronate can precipitate in their presence. In order to prevent any possible interaction, avoid joint administration with other intra-articular products. There is no known interaction with other local anesthetics.
• CW161

  Jonexa Up should not be administeres to pregnant or breastfeeding women
• CW007

  The product should not be used if the package is damaged or broken
• CW999

  Do not administer Jonexa Up to patients with known hypersensitivity (allergy) to hyaluronic acid and / or other components of the product. Do not administer Jonexa Up to patients with acute or chronic dermatological disorders or an inflammatory and / or infectious type skin problem. Do not administer Jonexa Up to patients with coagulation defects and / or who are treated with anticoagulant medication.The use of Jonexa Up in any joint other than the knee and for other conditions has not been studied. Jonexa Up must be injected strictly into the intra-articular space following aseptic injection procedures. Jonexa Up should be administered with sterile Luer-lock needles. Do not inject into a blood vessel or surrounding tissues. To avoid pain after the injection, a recommendation should be given to keep the local site still after the injection. The syringe and the used needle should be discarded in a container provided for this purpose
• CW010

  EUDAMED did not publish a description for this code.

Primary placement in Italy; available across 1 country total.

Trade name

not provided

UDI-DI code

08056515860761

Basic UDI-DI

B-08056515860761

Reference / catalog number

PV00091

Issuing entity

GS1

Risk category

Class III

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

• 4.4 MU48

• P900402RESORBABLE FILLING AND RECONSTRUCTION DEVICES

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

Certificate health across this manufacturer's portfolio.